Shaun Bagai - Apr 14, 2025 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Executive Officer, Director
Signature
/s/ Shaun Bagai
Stock symbol
RNXT
Transactions as of
Apr 14, 2025
Transactions value $
$0
Form type
4
Date filed
4/16/2025, 05:18 PM
Previous filing
Apr 10, 2025
Next filing
Apr 16, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNXT Stock Option Award $0 +410K $0.00 410K Apr 14, 2025 Common Stock 410K $0.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 409,992 shares of the Issuer's common stock (187,812 shares of which are underlying incentive stock options and 222,180 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2029, and will expire on April 14, 2035.